SCROLL NEWS / DISCOVERY

Search headlines

Find the stories shaping the conversation.

Search mode
Refine results
Active filters Keyword All time

Results for " Q2 2027 " 6 found 🔀 AI-powered Shuffle

Is Salesforce Still The Business You Bought?

If you hold Salesforce (CRM), you likely bought into a subscription software provider known for steady growth and reliable cash generation. During its fiscal Q2 2027 earnings call in August, management noted that a $25 billion accelerated share repurchase was still under way.

trefis.com logo
Oct 12 • 5:29 PM EDT • Business • trefis.com
Squadron 42 opens for Steam wishlisting ahead of a planned Q2 2027 release

Cloud Imperium's single-player space epic Squadron 42, starring Mark Hamill and Gary Oldman, is now on Steam for wishlisting ahead of a Q2 2027 release.

eurogamer.net logo
Oct 11 • 7:43 AM EDT • Technology • eurogamer.net
Squadron 42 Storms Onto Steam With Surprisingly Low Minimum PC Requirements, but Fans Still Face a Wait Until Q2 2027

Cloud Imperium Games has opened Squadron 42's Steam page and released a new trailer, while some fans and content creators played the game.

wccftech.com logo
Oct 10 • 1:00 PM EDT • Technology • wccftech.com
‘Squadron 42’ Release Nears as Wishlist Opens on Steam From Cloud Imperium

Cloud Imperium Games’ “Squadron 42” is now available to wishlist on Steam ahead of its planned Q2 2027 release.

variety.com logo
Oct 10 • 11:00 AM EDT • Technology • variety.com
Is Marvell The Broad Chip Business You Think You Own?

Marvell Technology (MRVL) raised its revenue outlook again with its fiscal Q2 2027 results in late August. The size of the raise is the easy story. What fell out of management's script matters more, because the business you own has narrowed toward a single bet.

trefis.com logo
Sep 10 • 9:27 AM EDT • Business • trefis.com
😐 Neutral (7%)
ahah
100%
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights

Initial clinical response data for AlloNK® in refractory rheumatoid arthritis (RA) expected in first half of 2026 U.S. Food and Drug Administration (FDA) interaction to discuss potential pivotal trial design for AlloNK expected in first half of 2026 Strengthened board and executive leadership with deep immunology, commercial and financial expertise Robust balance sheet with cash, cash equivalents and investments of $108.0 million as of December 31, 2025, expected to fund operations into Q2 2027

finance.yahoo.com logo
Mar 10 • 4:05 PM EDT • Business • finance.yahoo.com